Ovid Therapeutics Inc.
Ovid Therapeutics Inc.（OVID）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · OVID · 截至 2026年6月9日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
2
近12个月
买卖比
2.00
Buy/Sell (by trades)
整体情绪
Ovid Therapeutics Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
OVID 季度内部人买卖趋势
OVID 内幕交易卖出 · OVID 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · OVID CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
OVID 高管卖出股份 · OVID 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 7, 2026 | PAPADOPOULOS STELIOS Director | Award | 17,578 | $45K | Form 4 |
| Apr 7, 2026 | Friedman Bart Director | Award | 8,789 | $22K | Form 4 |
| Apr 7, 2026 | Fitzgerald Kevin Joseph Director | Award | 17,578 | $45K | Form 4 |
| Mar 23, 2026 | LEVIN JEREMY M Executive Chairman · Director | Option | 47,333 | $66K | Form 4 |
| Feb 23, 2026 | ALEXANDER MARGARET A. President and CEO · Director | Sale | 11,656 | $17K | Form 4 |
| Feb 26, 2026 | Rona Jeffrey A CBFO | Award | 68,125 | — | Form 4 |
| Feb 23, 2026 | Rona Jeffrey A CBFO | Sale | 8,541 | $12K | Form 4 |
| Dec 15, 2025 | LEVIN JEREMY M CEO · Director | Other | 71,000 | — | Form 4 |
| Dec 8, 2025 | TAKEDA PHARMACEUTICAL CO LTD 10 percent owner | Other | 1,250,000 | — | Form 4 |
| Feb 26, 2025 | ALEXANDER MARGARET A. President and COO | Sale | 5,279 | $3K | Form 4 |
| Feb 26, 2025 | Rona Jeffrey A CBFO | Sale | 3,902 | $2K | Form 4 |
| Feb 20, 2025 | Rona Jeffrey A CBFO | Award | 43,750 | — | Form 4 |
| Feb 20, 2025 | ALEXANDER MARGARET A. President and COO | Award | 43,750 | — | Form 4 |
| Jan 27, 2025 | ALEXANDER MARGARET A. President and COO | Purchase | 6,810 | $5K | Form 4 |
| Mar 18, 2024 | LEVIN JEREMY M CEO · Director | Purchase | 18,248 | $50K | Form 4 |
| Feb 22, 2024 | Tardio Jason COO | Award | 28,125 | — | Form 4 |
| Feb 22, 2024 | Rona Jeffrey A CBFO | Award | 28,125 | — | Form 4 |
| Feb 22, 2024 | Perone Thomas Michael General Counsel, Secretary | Award | 28,125 | — | Form 4 |
| Dec 4, 2023 | LEVIN JEREMY M CEO · Director | Gift | 573,275 | — | Form 4 |
| Dec 4, 2023 | LEVIN JEREMY M CEO · Director | Gift | 573,275 | — | Form 4 |
| Sep 12, 2022 | Tardio Jason COO | Sale | 17,344 | $37K | Form 4 |
| Jul 1, 2022 | TAKEDA PHARMACEUTICAL CO LTD 10 percent owner | Other | 5,750,000 | — | Form 4 |
| Jul 1, 2022 | TAKEDA PHARMACEUTICAL CO LTD 10 percent owner | Other | 5,750,000 | — | Form 4 |
LEVIN JEREMY M
Executive Chairman · Director
日期
Mar 23
股数
47,333
均价
$1.40
总金额
$66K
ALEXANDER MARGARET A.
President and CEO · Director
日期
Feb 23
股数
11,656
均价
$1.45
总金额
$17K
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 OVID 内幕交易
OVID 内幕交易
Ovid Therapeutics Inc.（OVID）内幕交易数据来源于公司内部人（包括LEVIN JEREMY M (Executive Chairman · Director), Rona Jeffrey A (CBFO), PAPADOPOULOS STELIOS (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。OVID内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Ovid Therapeutics Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
OVID 内幕交易 · 5个问题Ovid Therapeutics Inc.（OVID）的内部人包括高管和董事，如LEVIN JEREMY M (Executive Chairman · Director), Rona Jeffrey A (CBFO), PAPADOPOULOS STELIOS (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026